HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner statement on the UN cloning debate

Washington, DC -- A statement from Dr. Alan I. Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science, on the debate over research cloning that is scheduled to begin at the United Nations on Thursday 21 October 2004:

"We realize that this issue generates intense debate. We have long opposed human cloning to produce babies as dangerous and irresponsible. But we believe that nuclear cell transplantation research - what is called research or therapeutic cloning - holds the potential to ease tremendous suffering and prolong life for countless millions of people. For that reason, this window of scientific and eventual clinical opportunity should not be shut prematurely.

"These positions are reflected in the measure sponsored by Belgium-a measure that clearly represents the mainstream of scientific and medical thinking in the United States and worldwide."


'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
20-Oct-2004


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
5. Science academies issue statements on energy efficiency, innovation
6. AAAS releases video and first board consensus statement on climate change
7. Draft environmental impact statement prepared for USAMRIID facilities at Fort Detrick
8. Environmental impact statement planned for USAMRIID facilities at Fort Detrick
9. The AIUM releases new statement regarding keepsake imaging
10. AGU statement on future of Earth and space science research at NASA
11. Amgens decision to block reinstatement of GDNF is faulted by a leading Parkinsons advocacy group

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: